They also brought forward some deferred tax expenses. A better measure of the underlying business is EBIT which increased 33% to $34.3m
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4E and Annual Report 2022
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.28%
!
$10.74

Ann: Appendix 4E and Annual Report 2022, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.74 |
Change
-0.030(0.28%) |
Mkt cap ! $537.8M |
Open | High | Low | Value | Volume |
$10.60 | $10.78 | $10.54 | $459.5K | 43.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 249 | $10.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.77 | 252 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 430 | 10.720 |
3 | 1039 | 10.710 |
3 | 240 | 10.700 |
2 | 245 | 10.690 |
3 | 214 | 10.680 |
Price($) | Vol. | No. |
---|---|---|
10.750 | 8 | 2 |
10.760 | 521 | 8 |
10.770 | 178 | 4 |
10.780 | 760 | 6 |
10.790 | 3096 | 3 |
Last trade - 14.13pm 16/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online